Mexiletine hydrochloride (≥99%) (CAS 5370-01-4)
QUICK LINKS
Mexiletine hydrochloride is a sodium channel blocker that inhibits the inward movement of sodium ions through the cell membrane. It functions by binding to the local anesthetic receptor site on the sodium channel, thereby blocking the influx of sodium ions during depolarization. This action results in a reduction of the rate of rise of the action potential and a decrease in the excitability of the cell. By modulating sodium channel activity, Mexiletine hydrochloride can alter the conduction of electrical impulses in excitable tissues, such as cardiac and neuronal cells. Mexiletine Hydrochloride′s mechanism of action involves stabilizing the neuronal membrane and reducing the repetitive firing of action potentials. Mexiletine hydrochloride may have antiarrhythmic effects by prolonging the refractory period of cardiac tissue. Mexiletine hydrochloride′s function involves modulating sodium channel activity to influence the conduction of electrical impulses in excitable tissues.
Mexiletine hydrochloride (≥99%) (CAS 5370-01-4) References
- Attenuating effect of mexiletine hydrochloride on herpetic pain in mice infected with herpes simplex virus. | Asano, K., et al. 2003. J Pharm Pharmacol. 55: 1365-70. PMID: 14607018
- Optically active mexiletine analogues as stereoselective blockers of voltage-gated Na(+) channels. | Franchini, C., et al. 2003. J Med Chem. 46: 5238-48. PMID: 14613326
- Neuroprotective effect of mexiletine in the central nervous system of diabetic rats. | Ates, O., et al. 2006. Mol Cell Biochem. 286: 125-31. PMID: 16541198
- Evaluation of the pharmacological activity of the major mexiletine metabolites on skeletal muscle sodium currents. | De Bellis, M., et al. 2006. Br J Pharmacol. 149: 300-10. PMID: 16921388
- Novel automated assay for the quality control of mexiletine hydrochloride formulations using sequential injection and on-line dilution. | Tzanavaras, PD., et al. 2008. J Pharm Biomed Anal. 48: 1254-60. PMID: 18930618
- Mexiletine effects on theophylline disposition. | Hurwitz, A., et al. 1991. Clin Pharmacol Ther. 50: 299-307. PMID: 1914365
- Mechanism of interaction between theophylline and mexiletine. | Ueno, K., et al. 1991. DICP. 25: 727-30. PMID: 1949927
- Extemporaneous formulation and stability testing of mexiletine hydrochloride solution. | Alexander Phd Rph, KS. and Kaushik, S. 2004. Int J Pharm Compd. 8: 147-52. PMID: 23924625
- A systematic review of the effectiveness of palliative interventions to treat rectal tenesmus in cancer. | Ní Laoire, Á., et al. 2017. Palliat Med. 31: 975-981. PMID: 28590211
- Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS). | Yamada, S., et al. 2018. BMJ Open. 8: e023041. PMID: 30206090
- Mexiletine hydrochloride in an infant with intractable epilepsy. | Kohyama, J., et al. 1988. Brain Dev. 10: 258-60. PMID: 3218706
- Curative Effect of Yangxin Dingji Capsule Combined With Mexiletine Hydrochloride on Postoperative Arrhythmia and Its Influences on the Vascular Endothelial Function in Coronary Bifurcation Lesions. | Sun, N., et al. 2022. Emerg Med Int. 2022: 4078895. PMID: 36081956
- Designer Gelators for the Crystallization of a Salt Active Pharmaceutical Ingredient-Mexiletine Hydrochloride. | Andrews, JL., et al. 2022. Cryst Growth Des. 22: 6775-6785. PMID: 36345390
- Pharmacokinetics of mexiletine enantiomers in healthy human subjects. A study of the in vivo serum protein binding, salivary excretion and red blood cell distribution of the enantiomers. | Kwok, DW., et al. 1995. Xenobiotica. 25: 1127-42. PMID: 8578769
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Mexiletine hydrochloride (≥99%), 50 mg | sc-203633 | 50 mg | $79.00 |